...
首页> 外文期刊>The Journal of Physiology >Cardiac sympathetic afferent reflex control of cardiac function in normal and chronic heart failure states
【24h】

Cardiac sympathetic afferent reflex control of cardiac function in normal and chronic heart failure states

机译:正常与慢性心力衰竭状态心脏功能的心脏病患者心功能

获取原文
获取原文并翻译 | 示例

摘要

The enhanced cardiac sympathetic afferent reflex' (CSAR) critically contributes to the exaggerated global sympathetic tone in chronic heart failure (CHF). However, a potential contribution of the cardio-cardiac reflex control of cardiac function in both normal and CHF states remains unknown. In this study, we evaluated the effects of direct activation or inhibition of the CSAR on cardiac function by pressure-volume (P-V) loop analysis in similar to 12-week sham-operated and myocardial infarcted (MI) rats. In sham rats, acute CSAR activation by epicardial application of bradykinin (BK) increased heart rate (HR), left ventricular systolic pressure (LVSP), the maximum first derivative of left ventricular pressure (dp/dt(max)), and the slope of the end-systolic P-V relationship (ESPVR), suggesting that acute CSAR activation in the normal state enhances myocardial contractility. CSAR activation also decreased left ventricular (LV) systolic and diastolic volumes with little effect on LV end-diastolic pressure (LVEDP) or the end-diastolic P-V relationship (EDPVR) in sham rats. Compared to sham, CHF rats exhibit a reduced increase in the slope of the ESPVR and dp/dt(max) in response to BK, indicating a poor contractile response to CSAR activation. Interestingly, BK application in CHF rats increased cardiac systolic and diastolic volumes and further increased the elevated LVEDP, neither of which was seen in sham rats. Following CSAR inhibition by epicardial lidocaine, blood pressure, HR, LVSP, dp/dt, LVEDP and ESPVR decreased in CHF rats whereas lidocaine had little effect in sham rats, indicating that the CSAR is tonically active in CHF and contributes to cardiac dysfunction. Furthermore, we found that epicardial lidocaine paradoxically decreased LV end-diastolic volume (preload) in CHF rats, which was not observed in sham rats. The decreased preload by lidocaine in CHF rats may be due to a reduction in peripheral vascular resistance since epicardial lidocaine significantly lowered peripheral (renal) sympathetic nerve activity in CHF rats but not in sham rats. Furthermore, chronic ablation of CSAR by epicardial application of a selective afferent neurotoxin, resiniferatoxin, selectively lowered diastolic blood pressure both at daytime and night-time with less effect on systolic blood pressure in CHF rats. Our data suggest that there is an imbalance between cardiac and peripheral responses to CSAR in CHF animals compared to sham-operated controls.
机译:增强的心脏交感神经传入反射'(CSAR)批判性地有助于巨大的全局交感神经调节(CHF)。然而,在正常和CHF状态中,心脏功能对心脏功能的潜在贡献仍然未知。在这项研究中,我们评估了通过压力体积(P-V)环分析的直接激活或抑制CSAR对心脏功能的影响,类似于12周假手术和心肌梗死(MI)大鼠。在假大鼠中,急性Csar激活通过心外膜施用Bradykinin(BK)增加心率(HR),左心室收缩压(LVSP),最大左心室压力的最大衍生物(DP / DT(MAX)),以及斜坡在最终 - 收缩式PV关系(ESPVR)中,表明正常状态下的急性CSAR活化增强了心肌收缩性。 CSAR活化还会减少左心室(LV)收缩型和舒张型体积,对Sham大鼠的LV端舒张压(LVEDP)或末端舒张性P-V关系(EDPVR)几乎没有影响。与Sham相比,CHF大鼠表现出响应BK的ESPVR和DP / DT(MAX)的斜率增加,表明对CSAR激活的不良收缩响应。有趣的是,在CHF大鼠中的BK应用增加心脏收缩和舒张型体积,并进一步增加了升高的LVEDP,其中没有在假大鼠中看到。在CHF大鼠中,血压,HR,LVSP,DP / DT,LVEDP和ESPVR抑制CSAR抑制后,LIDOCAIE在假大鼠的作用几乎没有效果,表明CSAR在CHF中有冷调活性,有助于心脏功能障碍。此外,我们发现心外膜利多卡因矛盾地减少了CHF大鼠的LV端舒张分体积(预载),在恶意大鼠中未观察到。利多卡因在CHF大鼠中降低的预载可能是由于外周血利多卡因的外周血血管阻力降低,因为心外膜LIDOCAIE显着降低了CHF大鼠的外周(肾脏)同情神经活性,但不是在假大鼠中。此外,通过表皮施加一种选择性传入神经毒素,树脂氧化素,在白天和夜间选择性降低舒张压,在白天和夜间中选择性地降低了舒张压的慢性消融,对CHF大鼠的收缩压血压较小。我们的数据表明,与假手术控制相比,CHF动物中对CSAR的心脏和外围响应之间存在不平衡。

著录项

  • 来源
    《The Journal of Physiology 》 |2017年第8期| 共16页
  • 作者单位

    Univ Nebraska Med Ctr Dept Anesthesiol 984455 Nebraska Med Ctr Omaha NE 68198 USA;

    Univ Nebraska Med Ctr Dept Cellular &

    Integrat Physiol 985850 Nebraska Med Ctr Omaha NE 68198;

    Univ Nebraska Med Ctr Dept Cellular &

    Integrat Physiol 985850 Nebraska Med Ctr Omaha NE 68198;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 人体生理学 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号